Dr. Abdul Abdellatif, MD, assistant professor, Baylor College of Medicine and primary investigator on the “Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Early Data Report of a Multicenter, Open-Label, Efficacy and Safety” Study, otherwise known as PROTECT, discusses the latest data from this study that was presented at the American Society of Nephrology (ASN) 2020 (Abstract PO2481). He also explains strategies to effectively manage uncontrolled gout within the vulnerable post-transplant population that will not compromise kidney function or transplantation.
Dr. Abdul Abdellatif is board certified in internal medicine and nephrology. He is a Fellow of the American Society of Nephrology practicing out of Houston, TX. Dr. Abdellatif received his medical degree from Universidad Autonoma de Guadalajara in Mexico. He went on to complete his residency and fellowship at the University of Texas Health Science Center at San Antonio. Dr. Abdellatif is the founder of Kidney Hypertension Transplant Clinic at Clear Lake Specialties in Webster, Texas. He is an Adjunct Assistant Professor of Medicine – Division of Nephrology at Baylor College of Medicine.